Cargando…

Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference

There is substantial biochemical, pathological, and genetic evidence that α-synuclein (A-syn) is a principal molecule in the pathogenesis of Parkinson disease (PD). We previously reported that total A-syn levels in cerebrospinal fluid (CSF), measured with the specific enzyme-linked immunosorbent ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishii, Ryotaro, Tokuda, Takahiko, Tatebe, Harutsugu, Ohmichi, Takuma, Kasai, Takashi, Nakagawa, Masanori, Mizuno, Toshiki, El-Agnaf, Omar M. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388641/ https://www.ncbi.nlm.nih.gov/pubmed/25849645 http://dx.doi.org/10.1371/journal.pone.0123162

Ejemplares similares

Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy
por: Kasai, Takashi, et al.
Publicado: (2016)

Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2018)

Increased levels of plasma total tau in adult Down syndrome
por: Kasai, Takashi, et al.
Publicado: (2017)

p62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions
por: Watanabe, Yoshihisa, et al.
Publicado: (2012)

Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease
por: Shinomoto, Makiko, et al.
Publicado: (2021)

Differential Expression of Alpha-Synuclein in Hippocampal Neurons
por: Taguchi, Katsutoshi, et al.
Publicado: (2014)

Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020)

Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients
por: Shinomoto, Makiko, et al.
Publicado: (2019)

Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS
por: Kasai, Takashi, et al.
Publicado: (2019)

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
por: Tatebe, Harutsugu, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics
por: Kojima, Yuta, et al.
Publicado: (2021)

The domestic cat as a natural animal model of Alzheimer’s disease
por: Chambers, James K., et al.
Publicado: (2015)

Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid
por: Kakuda, Keita, et al.
Publicado: (2019)

Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer’s disease
por: Kasai, Takashi, et al.
Publicado: (2017)

Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer’s disease diagnosis
por: Murakami, Kazuma, et al.
Publicado: (2016)

Prevalence of heterophilic antibodies in serum samples from horses in an equine hospital, and elimination of interference using chicken IgY
por: Dong, Bo, et al.
Publicado: (2021)

Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism?
por: Sakaue, Satoshi, et al.
Publicado: (2017)

Heterophile Antibody Interference led to Unneeded Chemotherapy in a Testicular Cancer Patient
por: Soares, Daniele G., et al.
Publicado: (2016)

Falsely elevated serum estradiol due to heterophile antibody interference: a case report
por: Atkins, Paul, et al.
Publicado: (2021)

Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease
por: Mizutani, Yasuaki, et al.
Publicado: (2023)

Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2023)

Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
por: Murakami, Hidetomo, et al.
Publicado: (2019)

SAT-613 Heterophile Antibody Interference Causing Elevated TSH Levels: A Challenging Diagnosis
por: Ansar, Muhammad, et al.
Publicado: (2019)

Diagnostic Value of Muscle [(11)C] PIB-PET in Inclusion Body Myositis
por: Noto, Yu-ichi, et al.
Publicado: (2020)

AN HETEROPHILE FACTOR IN RAGWEED POLLEN
por: Sammis, F. Eastty
Publicado: (1940)

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
por: Majbour, Nour K., et al.
Publicado: (2017)

Risk factors for neuropsychiatric symptoms in patients with Parkinson’s disease during COVID-19 pandemic in Japan
por: Kitani-Morii, Fukiko, et al.
Publicado: (2021)

Enzymatic properties and clinical associations of serum alpha‐galactosidase A in Parkinson's disease
por: Mizutani, Yasuaki, et al.
Publicado: (2023)

Proteomic Profiling of Extracellular Vesicles Isolated From Cerebrospinal Fluid of Former National Football League Players at Risk for Chronic Traumatic Encephalopathy
por: Muraoka, Satoshi, et al.
Publicado: (2019)

Heterophile binding of human antibodies to glycoproteins of retroviruses.
por: Cardoso, E. A.
Publicado: (1981)

The distribution of heterophilic antigens and their relationship with autoimmune diseases
por: Sun, Lijun, et al.
Publicado: (2023)

Proteomic Profiling of Extracellular Vesicles Separated from Plasma of Former National Football League Players at Risk for Chronic Traumatic Encephalopathy
por: Muraoka, Satoshi, et al.
Publicado: (2021)

Knockdown of the Drosophila Fused in Sarcoma (FUS) Homologue Causes Deficient Locomotive Behavior and Shortening of Motoneuron Terminal Branches
por: Sasayama, Hiroshi, et al.
Publicado: (2012)

Repeated spurious elevation of serum prostate-specific antigen values solved by chemiluminescence analysis: A possible interference by heterophilic antibodies
por: Domínguez, Arturo, et al.
Publicado: (2015)

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
por: Majbour, Nour K., et al.
Publicado: (2016)

ASSOCIATION OF LACTOFERRIN WITH SPECIFIC GRANULES IN RABBIT HETEROPHIL LEUKOCYTES
por: Baggiolini, M., et al.
Publicado: (1970)

THE IMMUNOLOGICAL PROPERTIES OF THE HETEROPHILE ANTIGEN AND SOMATIC POLYSACCHARIDE OF PNEUMOCOCCUS
por: Goebel, Walther F., et al.
Publicado: (1943)

CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
por: Majbour, Nour K., et al.
Publicado: (2020)

Characteristic Posterior-dominant Lower Limb Muscle Involvement in Limb-girdle Muscular Dystrophy due to a DNAJB6 Phe93Leu Mutation
por: Kojima, Yuta, et al.
Publicado: (2017)

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers
por: Vaikath, Nishant, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5mo7r5da58i33hr7j3sgr16esh